Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 62 entries
Sorted by: Best Match Show Resources per page
Best approaches to drug-resistance surveillance at the country level.

International journal of mycobacteriology

Cabibbe AM, Cirillo DM.
PMID: 28043601
Int J Mycobacteriol. 2016 Dec;5:S40-S41. doi: 10.1016/j.ijmyco.2016.09.010. Epub 2016 Oct 21.

In 2014, the World Health Organization (WHO) recommendation to include the endorsed rapid molecular technologies (Xpert MTB/RIF, line probe assays) into surveillance systems and surveys allowed the testing of more tuberculosis (TB) patients for drug resistance at country level...

Cite
Cabibbe AM, Cirillo DM. Best approaches to drug-resistance surveillance at the country level. Int J Mycobacteriol. 2016;5:S40-S41doi: 10.1016/j.ijmyco.2016.09.010.
Cabibbe, A. M., & Cirillo, D. M. (2016). Best approaches to drug-resistance surveillance at the country level. International journal of mycobacteriology, 5S40-S41. https://doi.org/10.1016/j.ijmyco.2016.09.010
Cabibbe, A M, and Cirillo, D M. "Best approaches to drug-resistance surveillance at the country level." International journal of mycobacteriology vol. 5 (2016): S40-S41. doi: https://doi.org/10.1016/j.ijmyco.2016.09.010
Cabibbe AM, Cirillo DM. Best approaches to drug-resistance surveillance at the country level. Int J Mycobacteriol. 2016 Dec;5:S40-S41. doi: 10.1016/j.ijmyco.2016.09.010. Epub 2016 Oct 21. PMID: 28043601.
Copy Download .nbib Format: NLM
Update on new approaches in the management of hepatocellular carcinoma.

Hepatic medicine : evidence and research

Cabibbo G, Antonucci M, Genco C.
PMID: 24367214
Hepat Med. 2010 Nov 26;2:163-73. doi: 10.2147/HMER.S7132.

Hepatocellular carcinoma (HCC) is a major health problem. It is currently the third cause of cancer-related death, it is highly prevalent in the Asia-Pacific region and Africa, and is increasing in Western countries. The natural history of HCC is...

Cite
Cabibbo G, Antonucci M, Genco C. Update on new approaches in the management of hepatocellular carcinoma. Hepat Med. 2010;2:163-73doi: 10.2147/HMER.S7132.
Cabibbo, G., Antonucci, M., & Genco, C. (2010). Update on new approaches in the management of hepatocellular carcinoma. Hepatic medicine : evidence and research, 2163-73. https://doi.org/10.2147/HMER.S7132
Cabibbo, Giuseppe, et al. "Update on new approaches in the management of hepatocellular carcinoma." Hepatic medicine : evidence and research vol. 2 (2010): 163-73. doi: https://doi.org/10.2147/HMER.S7132
Cabibbo G, Antonucci M, Genco C. Update on new approaches in the management of hepatocellular carcinoma. Hepat Med. 2010 Nov 26;2:163-73. doi: 10.2147/HMER.S7132. PMID: 24367214; PMCID: PMC3846806.
Copy Download .nbib Format: NLM
Post-FSW Cold-Rolling Simulation of ECAP Shear Deformation and Its Microstructure Role Combined to Annealing in a FSWed AA5754 Plate Joint.

Materials (Basel, Switzerland)

Cabibbo M, Paoletti C, Ghat M, Forcellese A, Simoncini M.
PMID: 31075986
Materials (Basel). 2019 May 09;12(9). doi: 10.3390/ma12091526.

Friction stir welds are considered reliable joints for their lack of voids, cracks and distortions. When compared to the base material, friction stir welding (FSW) joints typically exhibit finer grain structured (especially at the nugget zone, NZ). Similarly, refined...

Cite
Cabibbo M, Paoletti C, Ghat M, et al. Post-FSW Cold-Rolling Simulation of ECAP Shear Deformation and Its Microstructure Role Combined to Annealing in a FSWed AA5754 Plate Joint. Materials (Basel). 2019;12(9)doi: 10.3390/ma12091526.
Cabibbo, M., Paoletti, C., Ghat, M., Forcellese, A., & Simoncini, M. (2019). Post-FSW Cold-Rolling Simulation of ECAP Shear Deformation and Its Microstructure Role Combined to Annealing in a FSWed AA5754 Plate Joint. Materials (Basel, Switzerland), 12(9), . https://doi.org/10.3390/ma12091526
Cabibbo, Marcello, et al. "Post-FSW Cold-Rolling Simulation of ECAP Shear Deformation and Its Microstructure Role Combined to Annealing in a FSWed AA5754 Plate Joint." Materials (Basel, Switzerland) vol. 12,9 (2019). doi: https://doi.org/10.3390/ma12091526
Cabibbo M, Paoletti C, Ghat M, Forcellese A, Simoncini M. Post-FSW Cold-Rolling Simulation of ECAP Shear Deformation and Its Microstructure Role Combined to Annealing in a FSWed AA5754 Plate Joint. Materials (Basel). 2019 May 09;12(9). doi: 10.3390/ma12091526. PMID: 31075986; PMCID: PMC6539944.
Copy Download .nbib Format: NLM
Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study.

Journal of clinical tuberculosis and other mycobacterial diseases

Dohál M, Dvořáková V, Šperková M, Porvazník I, Cabibbe AM, Trovato A, Spitaleri A, Rasmussen EM, Pršo K, Škereňová M, Cirillo DM, Solovič I, Mokrý J.
PMID: 35005254
J Clin Tuberc Other Mycobact Dis. 2021 Dec 20;26:100292. doi: 10.1016/j.jctube.2021.100292. eCollection 2022 Feb.

OBJECTIVE: The resistance of DESIGN: A total of 495 patients with pulmonary TB, who were referred to National Reference Laboratory for Mycobacteriology (Vyšné Hágy, Slovakia) in the years 2018-2019, were studied. Out of the total of 495 patients, 4...

Cite
Dohál M, Dvořáková V, Šperková M, et al. Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study. J Clin Tuberc Other Mycobact Dis. 2021;26:100292doi: 10.1016/j.jctube.2021.100292.
Dohál, M., Dvořáková, V., Šperková, M., Porvazník, I., Cabibbe, A. M., Trovato, A., Spitaleri, A., Rasmussen, E. M., Pršo, K., Škereňová, M., Cirillo, D. M., Solovič, I., & Mokrý, J. (2022). Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study. Journal of clinical tuberculosis and other mycobacterial diseases, 26100292. https://doi.org/10.1016/j.jctube.2021.100292
Dohál, Matúš, et al. "Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study." Journal of clinical tuberculosis and other mycobacterial diseases vol. 26 (2022): 100292. doi: https://doi.org/10.1016/j.jctube.2021.100292
Dohál M, Dvořáková V, Šperková M, Porvazník I, Cabibbe AM, Trovato A, Spitaleri A, Rasmussen EM, Pršo K, Škereňová M, Cirillo DM, Solovič I, Mokrý J. Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study. J Clin Tuberc Other Mycobact Dis. 2021 Dec 20;26:100292. doi: 10.1016/j.jctube.2021.100292. eCollection 2022 Feb. PMID: 35005254; PMCID: PMC8717600.
Copy Download .nbib Format: NLM
The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma.

Journal of hepatology

Cabibbo G, Singal AG.
PMID: 34843751
J Hepatol. 2022 Feb;76(2):262-264. doi: 10.1016/j.jhep.2021.11.021. Epub 2021 Nov 26.

No abstract available.

Cite
Cabibbo G, Singal AG. The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2021;76(2):262-264doi: 10.1016/j.jhep.2021.11.021.
Cabibbo, G., & Singal, A. G. (2022). The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma. Journal of hepatology, 76(2), 262-264. https://doi.org/10.1016/j.jhep.2021.11.021
Cabibbo, Giuseppe, and Singal, Amit G. "The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma." Journal of hepatology vol. 76,2 (2022): 262-264. doi: https://doi.org/10.1016/j.jhep.2021.11.021
Cabibbo G, Singal AG. The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2022 Feb;76(2):262-264. doi: 10.1016/j.jhep.2021.11.021. Epub 2021 Nov 26. PMID: 34843751.
Copy Download .nbib Format: NLM
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.

Targeted oncology

Orsi G, Tovoli F, Dadduzio V, Vivaldi C, Brunetti O, Ielasi L, Conti F, Rovesti G, Gramantieri L, Rizzato MD, Pecora I, Argentiero A, Teglia F, Lonardi S, Salani F, Granito A, Zagonel V, Marisi G, Cabibbo G, Foschi FG, Benevento F, Cucchetti A, Piscaglia F, Cascinu S, Scartozzi M, Casadei-Gardini A.
PMID: 33113041
Target Oncol. 2020 Dec;15(6):809-810. doi: 10.1007/s11523-020-00765-3.

An Online First version of this article was made available online at https://link.springer.com/article/10.1007/s11523-020-00757-3 on 12 October 2020. Errors were subsequently identified in the article, and the following corrections should be noted.

Cite
Orsi G, Tovoli F, Dadduzio V, et al. Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma. Target Oncol. 2020;15(6):809-810doi: 10.1007/s11523-020-00765-3.
Orsi, G., Tovoli, F., Dadduzio, V., Vivaldi, C., Brunetti, O., Ielasi, L., Conti, F., Rovesti, G., Gramantieri, L., Rizzato, M. D., Pecora, I., Argentiero, A., Teglia, F., Lonardi, S., Salani, F., Granito, A., Zagonel, V., Marisi, G., Cabibbo, G., Foschi, F. G., Benevento, F., Cucchetti, A., Piscaglia, F., Cascinu, S., Scartozzi, M., & Casadei-Gardini, A. (2020). Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma. Targeted oncology, 15(6), 809-810. https://doi.org/10.1007/s11523-020-00765-3
Orsi, Giulia, et al. "Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma." Targeted oncology vol. 15,6 (2020): 809-810. doi: https://doi.org/10.1007/s11523-020-00765-3
Orsi G, Tovoli F, Dadduzio V, Vivaldi C, Brunetti O, Ielasi L, Conti F, Rovesti G, Gramantieri L, Rizzato MD, Pecora I, Argentiero A, Teglia F, Lonardi S, Salani F, Granito A, Zagonel V, Marisi G, Cabibbo G, Foschi FG, Benevento F, Cucchetti A, Piscaglia F, Cascinu S, Scartozzi M, Casadei-Gardini A. Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma. Target Oncol. 2020 Dec;15(6):809-810. doi: 10.1007/s11523-020-00765-3. PMID: 33113041.
Copy Download .nbib Format: NLM
The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma.

Journal of hepatology

Cabibbo G, Singal AG.
PMID: 34843751
J Hepatol. 2021 Nov 26; doi: 10.1016/j.jhep.2021.11.021. Epub 2021 Nov 26.

No abstract available.

Cite
Cabibbo G, Singal AG. The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2021;doi: 10.1016/j.jhep.2021.11.021.
Cabibbo, G., & Singal, A. G. (2021). The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma. Journal of hepatology, . https://doi.org/10.1016/j.jhep.2021.11.021
Cabibbo, Giuseppe, and Singal, Amit G. "The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma." Journal of hepatology vol. (2021). doi: https://doi.org/10.1016/j.jhep.2021.11.021
Cabibbo G, Singal AG. The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2021 Nov 26; doi: 10.1016/j.jhep.2021.11.021. Epub 2021 Nov 26. PMID: 34843751.
Copy Download .nbib Format: NLM
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Pelizzaro F, Peserico G, D'Elia M, Cazzagon N, Russo FP, Vitale A, Giannini EG, Piccinnu M, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Farinati F.
PMID: 34580038
Dig Liver Dis. 2021 Sep 24; doi: 10.1016/j.dld.2021.08.025. Epub 2021 Sep 24.

BACKGROUND: An enhanced surveillance schedule has been proposed for cirrhotics with viral etiology, who are considered at extremely high-risk of hepatocellular carcinoma (HCC).AIMS: We compared the 3- and 6-months surveillance interval, evaluating cancer stage at diagnosis and patient survival.METHODS:...

Cite
Pelizzaro F, Peserico G, D'Elia M, et al. Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. Dig Liver Dis. 2021;doi: 10.1016/j.dld.2021.08.025.
Pelizzaro, F., Peserico, G., D'Elia, M., Cazzagon, N., Russo, F. P., Vitale, A., Giannini, E. G., Piccinnu, M., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Sacco, R., Cabibbo, G., Marra, F., Mega, A., Morisco, F., Gasbarrini, A., Svegliati-Baroni, G., Foschi, F. G., Olivani, A., Masotto, A., Nardone, G., Raimondo, G., Azzaroli, F., Vidili, G., Oliveri, F., Trevisani, F., Farinati, F. (2021). Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, . https://doi.org/10.1016/j.dld.2021.08.025
Pelizzaro, Filippo, et al. "Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. (2021). doi: https://doi.org/10.1016/j.dld.2021.08.025
Pelizzaro F, Peserico G, D'Elia M, Cazzagon N, Russo FP, Vitale A, Giannini EG, Piccinnu M, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Farinati F. Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. Dig Liver Dis. 2021 Sep 24; doi: 10.1016/j.dld.2021.08.025. Epub 2021 Sep 24. PMID: 34580038.
Copy Download .nbib Format: NLM
Use of WGS in Mycobacterium tuberculosis routine diagnosis.

International journal of mycobacteriology

Cirillo DM, Cabibbe AM, De Filippo MR, Trovato A, Simonetti T, Rossolini GM, Tortoli E.
PMID: 28043590
Int J Mycobacteriol. 2016 Dec;5:S252-S253. doi: 10.1016/j.ijmyco.2016.09.053. Epub 2016 Nov 11.

OBJECTIVE/BACKGROUND: Whole Genome Sequencing (WGS) is becoming affordable with overall costs comparable to other tests currently in use to perform the diagnosis of drug-resistant tuberculosis (TB) and cluster analysis. The WGS approach allows an "all-in-one" approach providing results on...

Cite
Cirillo DM, Cabibbe AM, De Filippo MR, et al. Use of WGS in Mycobacterium tuberculosis routine diagnosis. Int J Mycobacteriol. 2016;5:S252-S253doi: 10.1016/j.ijmyco.2016.09.053.
Cirillo, D. M., Cabibbe, A. M., De Filippo, M. R., Trovato, A., Simonetti, T., Rossolini, G. M., & Tortoli, E. (2016). Use of WGS in Mycobacterium tuberculosis routine diagnosis. International journal of mycobacteriology, 5S252-S253. https://doi.org/10.1016/j.ijmyco.2016.09.053
Cirillo, Daniela M, et al. "Use of WGS in Mycobacterium tuberculosis routine diagnosis." International journal of mycobacteriology vol. 5 (2016): S252-S253. doi: https://doi.org/10.1016/j.ijmyco.2016.09.053
Cirillo DM, Cabibbe AM, De Filippo MR, Trovato A, Simonetti T, Rossolini GM, Tortoli E. Use of WGS in Mycobacterium tuberculosis routine diagnosis. Int J Mycobacteriol. 2016 Dec;5:S252-S253. doi: 10.1016/j.ijmyco.2016.09.053. Epub 2016 Nov 11. PMID: 28043590.
Copy Download .nbib Format: NLM
High-Pressure Spark Plasma Sintering (HP SPS): A Promising and Reliable Method for Preparing Ti-Al-Si Alloys.

Materials (Basel, Switzerland)

Knaislová A, Novák P, Cygan S, Jaworska L, Cabibbo M.
PMID: 28772824
Materials (Basel). 2017 Apr 27;10(5). doi: 10.3390/ma10050465.

Ti-Al-Si alloys are prospective material for high-temperature applications. Due to low density, good mechanical properties, and oxidation resistance, these intermetallic alloys can be used in the aerospace and automobile industries. Ti-Al-Si alloys were prepared by powder metallurgy using reactive...

Cite
Knaislová A, Novák P, Cygan S, et al. High-Pressure Spark Plasma Sintering (HP SPS): A Promising and Reliable Method for Preparing Ti-Al-Si Alloys. Materials (Basel). 2017;10(5)doi: 10.3390/ma10050465.
Knaislová, A., Novák, P., Cygan, S., Jaworska, L., & Cabibbo, M. (2017). High-Pressure Spark Plasma Sintering (HP SPS): A Promising and Reliable Method for Preparing Ti-Al-Si Alloys. Materials (Basel, Switzerland), 10(5), . https://doi.org/10.3390/ma10050465
Knaislová, Anna, et al. "High-Pressure Spark Plasma Sintering (HP SPS): A Promising and Reliable Method for Preparing Ti-Al-Si Alloys." Materials (Basel, Switzerland) vol. 10,5 (2017). doi: https://doi.org/10.3390/ma10050465
Knaislová A, Novák P, Cygan S, Jaworska L, Cabibbo M. High-Pressure Spark Plasma Sintering (HP SPS): A Promising and Reliable Method for Preparing Ti-Al-Si Alloys. Materials (Basel). 2017 Apr 27;10(5). doi: 10.3390/ma10050465. PMID: 28772824; PMCID: PMC5459057.
Copy Download .nbib Format: NLM
An international round-robin calibration protocol for nanoindentation measurements.

Micron (Oxford, England : 1993)

Cabibbo M, Ricci P, Cecchini R, Rymuza Z, Sullivan J, Dub S, Cohen S.
PMID: 21890366
Micron. 2012 Feb;43(2):215-22. doi: 10.1016/j.micron.2011.07.016. Epub 2011 Aug 12.

Nanoindentation has become a common technique for measuring the hardness and elastic-plastic properties of materials, including coatings and thin films. In recent years, different nanoindenter instruments have been commercialised and used for this purpose. Each instrument is equipped with...

Cite
Cabibbo M, Ricci P, Cecchini R, et al. An international round-robin calibration protocol for nanoindentation measurements. Micron. 2011;43(2):215-22doi: 10.1016/j.micron.2011.07.016.
Cabibbo, M., Ricci, P., Cecchini, R., Rymuza, Z., Sullivan, J., Dub, S., & Cohen, S. (2012). An international round-robin calibration protocol for nanoindentation measurements. Micron (Oxford, England : 1993), 43(2), 215-22. https://doi.org/10.1016/j.micron.2011.07.016
Cabibbo, M, et al. "An international round-robin calibration protocol for nanoindentation measurements." Micron (Oxford, England : 1993) vol. 43,2 (2012): 215-22. doi: https://doi.org/10.1016/j.micron.2011.07.016
Cabibbo M, Ricci P, Cecchini R, Rymuza Z, Sullivan J, Dub S, Cohen S. An international round-robin calibration protocol for nanoindentation measurements. Micron. 2012 Feb;43(2):215-22. doi: 10.1016/j.micron.2011.07.016. Epub 2011 Aug 12. PMID: 21890366.
Copy Download .nbib Format: NLM
Needle track seeding following percutaneous procedures for hepatocellular carcinoma.

World journal of hepatology

Cabibbo G, Craxì A.
PMID: 21160966
World J Hepatol. 2009 Oct 31;1(1):62-6. doi: 10.4254/wjh.v1.i1.62.

Neoplastic seeding may arise after diagnostic or therapeutic percutaneous procedures for hepatocellular carcinoma. The true incidence of seeding with hepatocellular carcinoma is difficult to assess precisely, but a significant risk of seeding exists and is greater when performing diagnostic...

Cite
Cabibbo G, Craxì A. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol. 2009;1(1):62-6doi: 10.4254/wjh.v1.i1.62.
Cabibbo, G., & Craxì, A. (2009). Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World journal of hepatology, 1(1), 62-6. https://doi.org/10.4254/wjh.v1.i1.62
Cabibbo, Giuseppe, and Craxì, Antonio. "Needle track seeding following percutaneous procedures for hepatocellular carcinoma." World journal of hepatology vol. 1,1 (2009): 62-6. doi: https://doi.org/10.4254/wjh.v1.i1.62
Cabibbo G, Craxì A. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol. 2009 Oct 31;1(1):62-6. doi: 10.4254/wjh.v1.i1.62. PMID: 21160966; PMCID: PMC2999258.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 62 entries